1. Garcia‑Layana A., Figueroa M.S., Araiz J. Treatment of Exudative Age‑related Macular Degeneration: Focus on Aflibercept. Drugs Aging. 2015;32:797–807. DOI: 10.1007/s40266‑015‑0300‑y
2. WHO/World Health Organization. Age Related Macular Degeneration: Priority eye diseases. [Last accessed on 2011 Feb 6]. Available from: http://www.who.int/blindness/causes/priority/en/index8.html
3. Heier J.S., Brown D.M., Chong V., et al. Intravitreal aflibercept (VEGF trap‑eye) in wet age‑related macular degeneration. Ophthalmology. 2012;119:2537–2548. DOI: 10.1016/j.ophtha.2012.09.006
4. Budzinskaya M.V. Century. Age‑related macular degeneration. Annals of Ophthalmology = Vestnik oftal’mologii. 2014;130(6):56–61 (In Russ.)
5. Neroev V.V. Russian observational epidemiological non‑interventional study of patients with a wet form of age‑related macular degeneration. Russian ophthalmological journal = Rossiyskiy oftal’mologicheskiy zhurnal. 2011;4(2):4–9 (In Russ.)